US Stock MarketDetailed Quotes

Werewolf Therapeutics (HOWL)

Watchlist

0.9457
+0.0341+3.74%

Close Apr 17 16:00 ET

0.9500
+0.0043+0.45%

Post 20:01 ET

45.96MMarket Cap-0.71P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Werewolf Therapeutics (HOWL) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

-90.55%1.89M

-85.86%1.14M

-83.38%742K

Operating revenue

--0

-90.55%1.89M

--0

-85.86%1.14M

-83.38%742K

Cost of revenue

Gross profit

Operating expense

-19.61%60.68M

-53.72%9.42M

-8.16%15.73M

-12.74%17.54M

0.49%17.99M

24.87%75.48M

40.69%20.35M

13.04%17.12M

42.09%20.1M

7.29%17.9M

Selling and administrative expenses

-16.79%15.85M

-46.22%2.49M

-10.97%4.09M

-8.96%4.4M

-2.50%4.87M

2.01%19.05M

-4.01%4.62M

6.64%4.6M

5.85%4.83M

0.30%5M

-General and administrative expense

-16.79%15.85M

-46.22%2.49M

-10.97%4.09M

-8.96%4.4M

-2.50%4.87M

2.01%19.05M

-4.01%4.62M

6.64%4.6M

5.85%4.83M

0.30%5M

Research and development costs

-20.56%44.83M

-55.92%6.93M

-7.14%11.63M

-13.93%13.14M

1.64%13.12M

35.09%56.43M

62.99%15.73M

15.59%12.53M

59.36%15.27M

10.27%12.91M

Operating profit

17.55%-60.68M

53.72%-9.42M

8.16%-15.73M

7.48%-17.54M

-4.83%-17.99M

-81.70%-73.59M

-56.98%-20.35M

-85.10%-17.12M

-212.51%-18.96M

-40.41%-17.16M

Net non-operating interest income expense

-207.39%-2.17M

-2,016.67%-805K

-281.92%-644K

-169.28%-451K

-127.42%-266K

-52.84%2.02M

-95.65%42K

-63.54%354K

-34.51%651K

-27.99%970K

Non-operating interest income

-53.42%3.11M

-56.91%564K

-56.38%697K

-52.59%850K

-49.47%997K

-10.02%6.67M

-33.72%1.31M

-19.01%1.6M

-8.00%1.79M

29.89%1.97M

Non-operating interest expense

13.27%5.27M

8.05%1.37M

7.80%1.34M

13.92%1.3M

25.92%1.26M

48.33%4.66M

25.45%1.27M

24.15%1.24M

19.58%1.14M

483.14%1M

Other net income (expense)

90.30%2.02M

2,059.57%1.84M

-98.96%11K

16,900.00%168K

192.99%1.06M

-1,466.67%-94K

2,040.00%97K

4,340.00%1.06M

99.91%-1K

Special income (charges)

--0

----

---553K

--0

---553K

----

-Less:Other special charges

----

--553K

--0

----

--553K

----

Other non- operating income (expenses)

25.14%2.02M

2,059.57%1.84M

----

-99.32%11K

16,900.00%168K

241.42%1.62M

-1,466.67%-94K

2,040.00%97K

6,552.00%1.61M

99.91%-1K

Income before tax

13.75%-60.82M

58.92%-8.38M

1.82%-16.37M

-4.25%-17.98M

-11.71%-18.09M

-88.70%-70.52M

-69.96%-20.4M

-101.24%-16.67M

-238.35%-17.25M

-35.14%-16.19M

Income tax

Net income

13.75%-60.82M

58.92%-8.38M

1.82%-16.37M

-4.25%-17.98M

-11.71%-18.09M

-88.70%-70.52M

-69.96%-20.4M

-101.24%-16.67M

-238.35%-17.25M

-35.14%-16.19M

Net income continuous Operations

13.75%-60.82M

58.92%-8.38M

1.82%-16.37M

-4.25%-17.98M

-11.71%-18.09M

-88.70%-70.52M

-69.96%-20.4M

-101.24%-16.67M

-238.35%-17.25M

-35.14%-16.19M

Minority interest income

Net income attributable to the parent company

13.75%-60.82M

58.92%-8.38M

1.82%-16.37M

-4.25%-17.98M

-11.71%-18.09M

-88.70%-70.52M

-69.96%-20.4M

-101.24%-16.67M

-238.35%-17.25M

-35.14%-16.19M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

13.75%-60.82M

55.87%-8.38M

1.82%-16.37M

-4.25%-17.98M

-11.71%-18.09M

-88.70%-70.52M

-58.21%-18.99M

-101.24%-16.67M

-238.35%-17.25M

-35.14%-16.19M

Basic earnings per share

19.02%-1.32

63.04%-0.17

5.26%-0.36

0.00%-0.4

-2.56%-0.4

-55.24%-1.63

-39.39%-0.46

-65.22%-0.38

-185.71%-0.4

-14.71%-0.39

Diluted earnings per share

18.40%-1.33

56.52%-0.2

5.26%-0.36

6.98%-0.4

-2.56%-0.4

-55.24%-1.63

-39.39%-0.46

-65.22%-0.38

-207.14%-0.43

-14.71%-0.39

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	0	0	0	0	0	-90.55%1.89M	0	0	-85.86%1.14M	-83.38%742K
Operating revenue	--0	--0	--0	--0	--0	-90.55%1.89M	--0	--0	-85.86%1.14M	-83.38%742K
Cost of revenue
Gross profit
Operating expense	-19.61%60.68M	-53.72%9.42M	-8.16%15.73M	-12.74%17.54M	0.49%17.99M	24.87%75.48M	40.69%20.35M	13.04%17.12M	42.09%20.1M	7.29%17.9M
Selling and administrative expenses	-16.79%15.85M	-46.22%2.49M	-10.97%4.09M	-8.96%4.4M	-2.50%4.87M	2.01%19.05M	-4.01%4.62M	6.64%4.6M	5.85%4.83M	0.30%5M
-General and administrative expense	-16.79%15.85M	-46.22%2.49M	-10.97%4.09M	-8.96%4.4M	-2.50%4.87M	2.01%19.05M	-4.01%4.62M	6.64%4.6M	5.85%4.83M	0.30%5M
Research and development costs	-20.56%44.83M	-55.92%6.93M	-7.14%11.63M	-13.93%13.14M	1.64%13.12M	35.09%56.43M	62.99%15.73M	15.59%12.53M	59.36%15.27M	10.27%12.91M
Operating profit	17.55%-60.68M	53.72%-9.42M	8.16%-15.73M	7.48%-17.54M	-4.83%-17.99M	-81.70%-73.59M	-56.98%-20.35M	-85.10%-17.12M	-212.51%-18.96M	-40.41%-17.16M
Net non-operating interest income expense	-207.39%-2.17M	-2,016.67%-805K	-281.92%-644K	-169.28%-451K	-127.42%-266K	-52.84%2.02M	-95.65%42K	-63.54%354K	-34.51%651K	-27.99%970K
Non-operating interest income	-53.42%3.11M	-56.91%564K	-56.38%697K	-52.59%850K	-49.47%997K	-10.02%6.67M	-33.72%1.31M	-19.01%1.6M	-8.00%1.79M	29.89%1.97M
Non-operating interest expense	13.27%5.27M	8.05%1.37M	7.80%1.34M	13.92%1.3M	25.92%1.26M	48.33%4.66M	25.45%1.27M	24.15%1.24M	19.58%1.14M	483.14%1M
Other net income (expense)	90.30%2.02M	2,059.57%1.84M		-98.96%11K	16,900.00%168K	192.99%1.06M	-1,466.67%-94K	2,040.00%97K	4,340.00%1.06M	99.91%-1K
Special income (charges)	--0	--0	--0	--0	----	---553K	--0	--0	---553K	----
-Less:Other special charges	----	----	----	----	----	--553K	--0	----	--553K	----
Other non- operating income (expenses)	25.14%2.02M	2,059.57%1.84M	----	-99.32%11K	16,900.00%168K	241.42%1.62M	-1,466.67%-94K	2,040.00%97K	6,552.00%1.61M	99.91%-1K
Income before tax	13.75%-60.82M	58.92%-8.38M	1.82%-16.37M	-4.25%-17.98M	-11.71%-18.09M	-88.70%-70.52M	-69.96%-20.4M	-101.24%-16.67M	-238.35%-17.25M	-35.14%-16.19M
Income tax
Net income	13.75%-60.82M	58.92%-8.38M	1.82%-16.37M	-4.25%-17.98M	-11.71%-18.09M	-88.70%-70.52M	-69.96%-20.4M	-101.24%-16.67M	-238.35%-17.25M	-35.14%-16.19M
Net income continuous Operations	13.75%-60.82M	58.92%-8.38M	1.82%-16.37M	-4.25%-17.98M	-11.71%-18.09M	-88.70%-70.52M	-69.96%-20.4M	-101.24%-16.67M	-238.35%-17.25M	-35.14%-16.19M
Minority interest income
Net income attributable to the parent company	13.75%-60.82M	58.92%-8.38M	1.82%-16.37M	-4.25%-17.98M	-11.71%-18.09M	-88.70%-70.52M	-69.96%-20.4M	-101.24%-16.67M	-238.35%-17.25M	-35.14%-16.19M
Preferred stock dividends
Other preferred stock dividends			0					0
Net income attributable to common stockholders	13.75%-60.82M	55.87%-8.38M	1.82%-16.37M	-4.25%-17.98M	-11.71%-18.09M	-88.70%-70.52M	-58.21%-18.99M	-101.24%-16.67M	-238.35%-17.25M	-35.14%-16.19M
Basic earnings per share	19.02%-1.32	63.04%-0.17	5.26%-0.36	0.00%-0.4	-2.56%-0.4	-55.24%-1.63	-39.39%-0.46	-65.22%-0.38	-185.71%-0.4	-14.71%-0.39
Diluted earnings per share	18.40%-1.33	56.52%-0.2	5.26%-0.36	6.98%-0.4	-2.56%-0.4	-55.24%-1.63	-39.39%-0.46	-65.22%-0.38	-207.14%-0.43	-14.71%-0.39
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm